Foghorn TherapeuticsInc Stock Target Price and Analyst Consensus
| FHTX Stock | USD 5.21 0.05 0.97% |
The current analyst and expert consensus on Foghorn TherapeuticsInc is Strong Buy, with 2 strong buy opinions. The current projected Foghorn TherapeuticsInc target price consensus is 15.25 with 5 analyst opinions. The most common way Foghorn TherapeuticsInc analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Foghorn TherapeuticsInc executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Foghorn TherapeuticsInc. We strongly encourage you to use your own analysis of Foghorn TherapeuticsInc to validate this buy or sell advice. Foghorn TherapeuticsInc buy-or-sell recommendation module provides average expert sentiment on the projected Foghorn TherapeuticsInc target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Foghorn TherapeuticsInc to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn TherapeuticsInc guide.
Lowest Forecast 13.88 | Highest Forecast 16.93 | Target Price 15.25 |
Foghorn |
It's important to approach Foghorn TherapeuticsInc's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Foghorn TherapeuticsInc price targets
Foghorn TherapeuticsInc's stock target price is an estimate of its future price, usually made by analysts. Using Foghorn TherapeuticsInc's target price to determine if it is a suitable investment can be done through the following steps:- Look at Foghorn TherapeuticsInc's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Foghorn TherapeuticsInc's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Foghorn TherapeuticsInc Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Foghorn TherapeuticsInc is a key component of Foghorn TherapeuticsInc valuation and have some predictive power on the future returns of a Foghorn TherapeuticsInc.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Foghorn TherapeuticsInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Impulse Invested over 100 shares | |
 | Momentum Invested over 60 shares | |
 | Warren Buffett Holdings Invested few shares | |
Check out Macroaxis Advice on Foghorn TherapeuticsInc to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn TherapeuticsInc guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Foghorn Stock analysis
When running Foghorn TherapeuticsInc's price analysis, check to measure Foghorn TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn TherapeuticsInc is operating at the current time. Most of Foghorn TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Foghorn TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn TherapeuticsInc's price. Additionally, you may evaluate how the addition of Foghorn TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
The data published in Foghorn TherapeuticsInc's official financial statements usually reflect Foghorn TherapeuticsInc's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Foghorn TherapeuticsInc. For example, before you start analyzing numbers published by Foghorn accountants, it's critical to develop an understanding of what Foghorn TherapeuticsInc's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Foghorn TherapeuticsInc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Foghorn TherapeuticsInc's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Foghorn TherapeuticsInc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Foghorn TherapeuticsInc. Please utilize our Beneish M Score to check the likelihood of Foghorn TherapeuticsInc's management manipulating its earnings.